One in seven drug supply chain issue reports tied to drug shortages
Apr 10, 2024
Supply disruptions increased for drugs with and without reports at the start of the COVID-19 pandemic.
ACC: Semaglutide beneficial in obesity-related heart failure, type 2 diabetes
Apr 09, 2024
Larger reductions were seen in heart failure-related symptoms and physical limitations for patients with HFpEF and type 2 diabetes.
Nirmatrelvir-ritonavir does not speed up alleviation of COVID-19 symptoms
Apr 05, 2024
The time to sustained alleviation of COVID-19 symptoms was not significantly shorter with nirmatrelvir-ritonavir versus placebo.
Lixisenatide reduces motor disability progression in Parkinson’s disease
Apr 04, 2024
Lixisenatide results in less progression of motor disability than placebo at 12 months for individuals with early Parkinson’s disease.
Insulin out-of-pocket cost caps do not increase insulin use
Mar 26, 2024
Caps are associated with a reduction in insulin costs, mainly driven by patients enrolled in health savings accounts.
Medicare to cover Wegovy when patients also have heart disease
Mar 22, 2024
Medicare will now cover the popular weight-loss drug Wegovy if patients using it also have heart disease, US officials announced Thursday.
Risk profile IDs COVID-19 patients who will benefit from baricitinib
Feb 26, 2024
Baricitinib plus remdesivir was linked to a reduced risk of death and progression to invasive mechanical ventilation.
Prescription opioids linked to increased risk for serious fall events
Feb 20, 2024
The findings seen among adults of all ages, especially those aged 85 years or older; the risk was highest in the first 28 days after initiation.
High-concentration capsaicin patch can cut neuropathic pain intensity
Feb 07, 2024
During high-concentration capsaicin patch treatment, a significant decrease was seen in average daily morphine equivalent dose.
Biogen is dropping controversial Alzheimer’s drug Aduhelm
Jan 31, 2024
Biogen said it will shift its focus to a newer Alzheimer’s drug, Leqembi, which it markets in a partnership with Japan-based Eisai. Leqembi received FDA approval last year.